Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The aim is to study whether the budesonide component within the budesonide/ formoterol
combination inhaler has additive value in a model of "slow onset acute asthma" , namely three
AMP provocation tests performed on one day
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Albuterol Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate